Opening of connexin 43 hemichannels is increased by lowering intracellular redox potential.
Nonjunctional membrane in many cells contains connexin gap junction hemichannels (or connexons) that can open to allow permeation of small molecules. Opening of Cx43 hemichannels is infrequent in normal extracellular Ca(2+) and enhanced by low Ca(2+), positive membrane potentials, and dephosphorylation of critical residues. Here we report that lowering intracellular redox potential increases Cx43 hemichannel open probability under otherwise normal conditions. We studied dye uptake and single-channel activity in HeLa cells transfected with wild-type Cx43, Cx43 with enhanced GFP attached to its C terminus (Cx43-EGFP), and Cx43 with enhanced GFP attached to its N terminus (EGFP-Cx43). Dithiothreitol [(DTT) 10 mM], a membrane permeant-reducing agent, increased the rate of dye uptake by cells expressing Cx43 and Cx43-EGFP, but not by parental cells or cells expressing EGFP-Cx43. Induced dye uptake was blocked by La(3+), by a peptide gap junction and hemichannel blocker (gap 26), and by flufenamic acid. DTT increased Cx43-EGFP hemichannel opening at positive voltages. Bath application of reduced glutathione, a membrane impermeant-reducing agent, did not increase dye uptake, but glutathione in the recording pipette increased hemichannel opening at positive voltages, suggesting that it acted intracellularly. DTT caused little change in levels of surface Cx43 or Cx43-EGFP, or in intracellular pH. These findings suggest that lowering intracellular redox potential increases the opening of Cx43 and Cx43-EGFP hemichannels, possibly by action on cytoplasmic cysteine residues in the connexin C terminus.
Retamal
Mauricio A
MA
Núcleo Milenio Inmunología e Inmunoterapia, Departamento de Ciencias Fisiológicas, Pontificia Universidad Católica de Chile, Santiago 4860, Chile.
Schalper
Kurt A
KA
Shoji
Kenji F
KF
Bennett
Michael V L
MV
Sáez
Juan C
JC
D000818:Animals; D002021:Buffers; D002118:Calcium / Q000378:metabolism; D018031:Connexin 43 / Q000037:antagonists & inhibitors / Q000378:metabolism*; D004229:Dithiothreitol / Q000494:pharmacology; D004996:Ethidium / Q000378:metabolism; D005978:Glutathione / Q000378:metabolism; D049452:Green Fluorescent Proteins / Q000378:metabolism; D006367:HeLa Cells; D006801:Humans; D015640:Ion Channel Gating / Q000187:drug effects; D051379:Mice; D010084:Oxidation-Reduction / Q000187:drug effects; D010766:Phosphorylation / Q000187:drug effects; D021381:Protein Transport / Q000187:drug effects; D011993:Recombinant Fusion Proteins / Q000378:metabolism; D019163:Reducing Agents / Q000494:pharmacology
D002021:Buffers; D018031:Connexin 43; D011993:Recombinant Fusion Proteins; D019163:Reducing Agents; C485184:enhanced green fluorescent protein; D049452:Green Fluorescent Proteins; D004996:Ethidium; D005978:Glutathione; D002118:Calcium; D004229:Dithiothreitol